Articles

Iron-heme-Bach1 axis is involved in erythroblast adaptation to iron deficiency

Department of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan;Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan
Department of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan;Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan
Department of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan
Department of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan;AMED-CREST, Japan Agency for Medical Research and Development, Tokyo, Japan;Department of Experimental Immunology, Institute of Development, Aging and Cancer, Tohoku University, Japan
Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan;Center for Regulatory Epigenome and Diseases, Tohoku University Graduate School of Medicine, Sendai, Japan
Department of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan;AMED-CREST, Japan Agency for Medical Research and Development, Tokyo, Japan
Division of Epigenomics and Development, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan
Division of Epigenomics and Development, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan;Laboratory of Genome and Epigenome Dynamics, Department of Applied Molecular Biosciences, Graduate School of Bioagricultural Sciences, Nagoya University, Aichi, Japan
Department of Research and Development, Cellspect Co. Ltd., Morioka, Japan
Division of Systems Bioscience for Drug Discovery, Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan
AMED-CREST, Japan Agency for Medical Research and Development, Tokyo, Japan;Division of Epigenomics and Development, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan
Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan;Center for Regulatory Epigenome and Diseases, Tohoku University Graduate School of Medicine, Sendai, Japan
Department of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan;AMED-CREST, Japan Agency for Medical Research and Development, Tokyo, Japan;Center for Regulatory Epigenome and Diseases, Tohoku University Graduate School of Medicine, Sendai, Japan
Vol. 102 No. 3 (2017): March, 2017 https://doi.org/10.3324/haematol.2016.151043